Xtl Biopharmaceuticals

XTLBNasdaq Israel Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$7.225 M

$2.94 +2.44%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

946,243,356

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#451Addex TherapeuticsADXN$7.34M
#452Xenetic BiosciencesXBIO$7.26M
#453Xtl BiopharmaceuticalsXTLB$7.22M
#454Cadrenal TherapeuticsCVKD$6.96M
#455ImunonIMNN$6.77M

Where these numbers come from

Share counts and financials for Xtl Biopharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.